<p>當你購買一家公司的股票時，值得考慮它可能會失敗的可能性，你可能會失去你的投資。但當你選擇一家真正繁榮的公司時，你可以獲得超過 100% 的收益。長期以來，<strong>Extendicare Inc.</strong>（多倫多證券交易所代碼：EXE）的股東對此應該非常清楚，因為該股票在五年內上漲了 167%。在過去一週內，它甚至上漲了 8.7%。</p>
<p>在過去一週強勁上漲之後，值得看看長期回報是否是由基本面改善所驅動的。</p>
<p>這項技術可能會取代計算機：發現 20 只正在努力使量子計算成為現實的股票。</p>
<p>不可否認，市場有時是有效的，但價格並不總是反映基礎業務的表現。考慮市場對一家公司的看法如何變化的一個不完美但簡單的方法是比較每股收益（EPS）的變化與股價的變動。</p>
<p>在五年的股價增長期間，Extendicare 實現了每股收益（EPS）年複合增長率為 110%。EPS 的增長比同期每年 22% 的股價增長更為顯著。因此，市場似乎對該公司變得相對悲觀。</p>
<p>下圖描繪了 EPS 隨時間的變化（點擊圖片可揭示確切數值）。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/379493-earnings-per-share-growth-1-dark-2/1758708780452?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/379493-earnings-per-share-growth-1-dark-2/1758708780452"/></p>
<p>TSX:EXE 每股收益增長 2025 年 9 月 24 日</p>
<p>我們認為內部人士在過去一年進行了大量購買是積極的。話雖如此，大多數人認為收益和收入增長趨勢是更有意義的商業指導。在買入或賣出股票之前，我們始終建議仔細審查歷史增長趨勢，相關信息可在此處獲取。</p>
<h2>股息情況如何？</h2>
<p>考慮任何給定股票的總股東回報以及股價回報是很重要的。股價回報僅反映股價的變化，而總股東回報（TSR）則包括股息的價值（假設它們被再投資）以及任何折扣資本籌集或分拆的好處。可以公平地説，TSR 為支付股息的股票提供了更完整的圖景。我們注意到，Extendicare 在過去 5 年的 TSR 為 264%，這比上述的股價回報更好。公司支付的股息因此提升了總股東回報。</p>
<h2>不同的視角</h2>
<p>很高興看到 Extendicare 的股東在過去一年獲得了 59% 的總股東回報。這包括股息。這比過去五年的年化回報 29% 要好，暗示公司最近表現更佳。在最佳情況下，這可能暗示一些真正的商業動能，意味着現在可能是深入研究的好時機。我發現從長期來看觀察股價作為商業表現的代理非常有趣。但要真正獲得洞察，我們還需要考慮其他信息。舉個例子：我們發現 <strong>Extendicare 有 1 個警告信號</strong> 你應該注意。</p>
<p>還有很多其他公司內部人士正在購買股票。你可能不想錯過這份 <strong>免費的</strong> 被低估的小型公司的名單，內部人士正在購買。</p>
<p><em>請注意，本文中引用的市場回報反映了目前在加拿大交易所交易的股票的市場加權平均回報。</em></p>

<p>Extendicare Inc.（多倫多證券交易所代碼：EXE）在五年內股價上漲了 167%，最近上漲了 8.7%。儘管每股收益（EPS）年增長率達到 110%，市場的看法似乎仍然悲觀，因為股價年增長僅為 22%。五年來的總股東回報率（TSR）為 264%，得益於分紅。最近，股東在過去一年中享受到了 59% 的 TSR，顯示出潛在的業務動能。然而，由於公司被發現有一個警示信號，建議保持謹慎</p>

<p>When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But when you pick a company that is really flourishing, you can <em>make</em> more than 100%. Long term <strong>Extendicare Inc.</strong> (TSE:EXE) shareholders would be well aware of this, since the stock is up 167% in five years. It's even up 8.7% in the last week.</p>
<div class="lb-trans"><p>當你購買一家公司的股票時，值得考慮它可能會失敗的可能性，你可能會失去你的投資。但當你選擇一家真正繁榮的公司時，你可以獲得超過 100% 的收益。長期以來，<strong>Extendicare Inc.</strong>（多倫多證券交易所代碼：EXE）的股東對此應該非常清楚，因為該股票在五年內上漲了 167%。在過去一週內，它甚至上漲了 8.7%。</p>
</div><p>After a strong gain in the past week, it's worth seeing if longer term returns have been driven by improving fundamentals.</p>
<div class="lb-trans"><p>在過去一週強勁上漲之後，值得看看長期回報是否是由基本面改善所驅動的。</p>
</div><p>This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.</p>
<div class="lb-trans"><p>這項技術可能會取代計算機：發現 20 只正在努力使量子計算成為現實的股票。</p>
</div><p>There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.</p>
<div class="lb-trans"><p>不可否認，市場有時是有效的，但價格並不總是反映基礎業務的表現。考慮市場對一家公司的看法如何變化的一個不完美但簡單的方法是比較每股收益（EPS）的變化與股價的變動。</p>
</div><p>During five years of share price growth, Extendicare achieved compound earnings per share (EPS) growth of 110% per year. The EPS growth is more impressive than the yearly share price gain of 22% over the same period. Therefore, it seems the market has become relatively pessimistic about the company.</p>
<div class="lb-trans"><p>在五年的股價增長期間，Extendicare 實現了每股收益（EPS）年複合增長率為 110%。EPS 的增長比同期每年 22% 的股價增長更為顯著。因此，市場似乎對該公司變得相對悲觀。</p>
</div><p>The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).</p>
<div class="lb-trans"><p>下圖描繪了 EPS 隨時間的變化（點擊圖片可揭示確切數值）。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/379493-earnings-per-share-growth-1-dark-2/1758708780452" alt="" original-src="https://images.simplywall.st/asset/chart/379493-earnings-per-share-growth-1-dark-2/1758708780452"/></p>
<p>TSX:EXE Earnings Per Share Growth September 24th 2025</p>
<div class="lb-trans"><p>TSX:EXE 每股收益增長 2025 年 9 月 24 日</p>
</div><p>We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here..</p>
<div class="lb-trans"><p>我們認為內部人士在過去一年進行了大量購買是積極的。話雖如此，大多數人認為收益和收入增長趨勢是更有意義的商業指導。在買入或賣出股票之前，我們始終建議仔細審查歷史增長趨勢，相關信息可在此處獲取。</p>
</div><h2>What About Dividends?</h2>
<div class="lb-trans"><h2>股息情況如何？</h2>
</div><p>It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. We note that for Extendicare the TSR over the last 5 years was 264%, which is better than the share price return mentioned above. The dividends paid by the company have thusly boosted the <em>total</em> shareholder return.</p>
<div class="lb-trans"><p>考慮任何給定股票的總股東回報以及股價回報是很重要的。股價回報僅反映股價的變化，而總股東回報（TSR）則包括股息的價值（假設它們被再投資）以及任何折扣資本籌集或分拆的好處。可以公平地説，TSR 為支付股息的股票提供了更完整的圖景。我們注意到，Extendicare 在過去 5 年的 TSR 為 264%，這比上述的股價回報更好。公司支付的股息因此提升了總股東回報。</p>
</div><h2>A Different Perspective</h2>
<div class="lb-trans"><h2>不同的視角</h2>
</div><p>It's nice to see that Extendicare shareholders have received a total shareholder return of 59% over the last year. That's including the dividend. That's better than the annualised return of 29% over half a decade, implying that the company is doing better recently. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted <strong>1 warning sign for Extendicare</strong> you should be aware of.</p>
<div class="lb-trans"><p>很高興看到 Extendicare 的股東在過去一年獲得了 59% 的總股東回報。這包括股息。這比過去五年的年化回報 29% 要好，暗示公司最近表現更佳。在最佳情況下，這可能暗示一些真正的商業動能，意味着現在可能是深入研究的好時機。我發現從長期來看觀察股價作為商業表現的代理非常有趣。但要真正獲得洞察，我們還需要考慮其他信息。舉個例子：我們發現 <strong>Extendicare 有 1 個警告信號</strong> 你應該注意。</p>
</div><p>There are plenty of other companies that have insiders buying up shares. You probably do <strong>not</strong> want to miss this <strong>free</strong> list of undervalued small cap companies that insiders are buying.</p>
<div class="lb-trans"><p>還有很多其他公司內部人士正在購買股票。你可能不想錯過這份 <strong>免費的</strong> 被低估的小型公司的名單，內部人士正在購買。</p>
</div><p><em>Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Canadian exchanges.</em></p>
<div class="lb-trans"><p><em>請注意，本文中引用的市場回報反映了目前在加拿大交易所交易的股票的市場加權平均回報。</em></p>
</div>

Extendicare（TSE:EXE）的五年盈利增長低於股東 29% 的年度回報率